Duotrav

DRUG5 trials

Sponsors

Alcon Research, Ministry of Health, Malaysia, Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Kasr El Aini Hospital

Conditions

GlaucomaOcular HypertensionOpen-angle GlaucomaPrimary Open Angle Glaucoma

Phase 3

Safety and Efficacy Study of DuoTrav APS Versus DuoTrav

WithdrawnNCT00862472

Alcon ResearchOcular Hypertension, Open-angle Glaucoma

Start: 2009-03-31End: 2009-06-30Updated: 2012-01-18

A Study of Ganfort Versus Duotrav in Patients With Primary Open Angle Glaucoma or Ocular Hypertension

CompletedNCT01168414

Ministry of Health, MalaysiaOcular Hypertension, Primary Open Angle Glaucoma

Start: 2010-08-31End: 2011-02-28Updated: 2011-07-08

Phase 4

DuoTrav® Eye Drops As Replacement Therapy Program

CompletedNCT00828906

Alcon ResearchOcular Hypertension, Open-angle Glaucoma

Start: 2009-02-28Updated: 2012-09-20

Unknown Phase

Real World Data Study Assessing The Persistency Of Xalacom And The Other Fixed Dose Combination Products, Duotrav And Ganfort, In The United Kingdom

CompletedNCT01206361

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Glaucoma, Ocular Hypertension

Start: 2010-02-28End: 2010-08-31Updated: 2021-02-02

Bimatoprost/Timolol Versus Travoprost/Timolol

CompletedNCT01542710

Kasr El Aini HospitalGlaucoma

Start: 2011-01-31End: 2011-12-31Updated: 2012-03-02